Research output per year
Research output per year
Personal profile
Research Biography
I am a clinical epidemiologist, biostatistician, and pharmacist with a primary research interest in the health applications of generative AI, and the use of biological, chemical, and clinical markers to guide decisions regarding the most appropriate use of medicines (precision medicine).
I have deep expertise in many areas of clinical data science, including prediction models (machine learning), generative AI, survival analysis, evaluation of treatment heterogeneity, clinical trial analysis, and meta-analysis. I have a high degree of proficiency in both R and python programming languages.
Research Interests
- Precision medicine
- Machine learning
- Health applications of generative artificial intelligence
- Predicting therapeutic and adverse outcomes of cancer medicines in advanced cancer
- Novel biomarkers for precision dosing of medicines
- Evidence-based medicine, clinical epidemiology, pharmacometrics, decision analysis, pharmacoeconomics and meta-analysis
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Supervision
- Registered
Research Areas
- Digital health and technology
- Knowledge discovery, AI and data mining
- Medical biosciences
Supervisory Interests
- Generative artificial intelligence
- Clinical epidemiology
- Personalised medicine
- Biomarkers
- Machine learning
- Biostatistics
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized controlled trials
Sorich, M., Wiese, M., Rowland, A., Kichenadasse, G., McKinnon, R. & Karapetis, C., 1 Jan 2015, In: Annals of Oncology. 26, 1, p. 13-21 9 p.Research output: Contribution to journal › Review article › peer-review
435 Citations (Scopus) -
Association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non-small cell lung cancer
Kichenadasse, G., Miners, J. O., Mangoni, A. A., Rowland, A., Hopkins, A. M. & Sorich, M. J., Apr 2020, In: JAMA Oncology. 6, 4, p. 512-518 7 p.Research output: Contribution to journal › Article › peer-review
236 Citations (Scopus) -
Health Disinformation Use Case Highlighting the Urgent Need for Artificial Intelligence Vigilance: Weapons of Mass Disinformation
Menz, B. D., Modi, N. D., Sorich, M. J. & Hopkins, A. M., 2 Jan 2024, In: JAMA Internal Medicine. 184, 1, p. 92-96 5 p.Research output: Contribution to journal › Review article › peer-review
Open AccessFile35 Citations (Scopus)9 Downloads (Pure) -
Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure
Rowland, A., Ruanglertboon, W., Van Dyk, M., Wijayakumara, D. D., Wood, L. S., Meech, R., Mackenzie, P. I., Rodrigues, A. D., Marshall, J. C. & Sorich, M. J., 1 Jan 2019, In: British Journal of Clinical Pharmacology. 85, 1, p. 216-226 11 p.Research output: Contribution to journal › Article › peer-review
Open Access66 Citations (Scopus) -
Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration
Modi, N. D., Abuhelwa, A. Y., McKinnon, R. A., Boddy, A. V., Haseloff, M., Wiese, M. D., Hoffmann, T. C., Perakslis, E. D., Rowland, A., Sorich, M. J. & Hopkins, A. M., Sept 2022, In: JAMA Oncology. 8, 9, p. 1310-1316 7 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile15 Citations (Scopus)61 Downloads (Pure)
Activities
- 1 Other
-
Pharmacogenomics, Australian Pharmaceutical Formulary
Haddy, C. A. (Participant), McKinnon, R. (Participant), Sorich, M. (Participant) & Ward, M. (Participant)
2006 → …Activity: Other activity types › Other